Cargando…
SARS-CoV-2 vaccines: fast track versus efficacy
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906641/ https://www.ncbi.nlm.nih.gov/pubmed/33659918 http://dx.doi.org/10.1016/S2666-5247(21)00034-3 |
| _version_ | 1783655332553162752 |
|---|---|
| author | Alkandari, Dana Herbert, Jenny A Alkhalaf, Moustafa A Yates, Carol Panagiotou, Stavros |
| author_facet | Alkandari, Dana Herbert, Jenny A Alkhalaf, Moustafa A Yates, Carol Panagiotou, Stavros |
| author_sort | Alkandari, Dana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7906641 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Author(s). Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79066412021-02-26 SARS-CoV-2 vaccines: fast track versus efficacy Alkandari, Dana Herbert, Jenny A Alkhalaf, Moustafa A Yates, Carol Panagiotou, Stavros Lancet Microbe Comment The Author(s). Published by Elsevier Ltd. 2021-03 2021-02-09 /pmc/articles/PMC7906641/ /pubmed/33659918 http://dx.doi.org/10.1016/S2666-5247(21)00034-3 Text en © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Alkandari, Dana Herbert, Jenny A Alkhalaf, Moustafa A Yates, Carol Panagiotou, Stavros SARS-CoV-2 vaccines: fast track versus efficacy |
| title | SARS-CoV-2 vaccines: fast track versus efficacy |
| title_full | SARS-CoV-2 vaccines: fast track versus efficacy |
| title_fullStr | SARS-CoV-2 vaccines: fast track versus efficacy |
| title_full_unstemmed | SARS-CoV-2 vaccines: fast track versus efficacy |
| title_short | SARS-CoV-2 vaccines: fast track versus efficacy |
| title_sort | sars-cov-2 vaccines: fast track versus efficacy |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906641/ https://www.ncbi.nlm.nih.gov/pubmed/33659918 http://dx.doi.org/10.1016/S2666-5247(21)00034-3 |
| work_keys_str_mv | AT alkandaridana sarscov2vaccinesfasttrackversusefficacy AT herbertjennya sarscov2vaccinesfasttrackversusefficacy AT alkhalafmoustafaa sarscov2vaccinesfasttrackversusefficacy AT yatescarol sarscov2vaccinesfasttrackversusefficacy AT panagiotoustavros sarscov2vaccinesfasttrackversusefficacy |